A newborn’s risk of exhibiting drug withdrawal symptoms and respiratory abnormalities appears to increase with prenatal exposure to certain antidepressants, according to two new studies.



Before prescribing this type of medication to pregnant women, the doctors are urged by researchers to carefully consider these findings. The risk of a respiratory disorder in pregnant women is increased by the use of SSRI antidepressants. The respiratory disorder includes persistent pulmonary hypertension (PPHN) in the newborn by 600%. This was the finding of a new retrospective study, and it included 377 women whose infants had the disorder.



Via: New Scientist